Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis

• Status: Completed
• Trial end date: 2020-11-30
• Target enrollment: 0
• Participant gender: All

Summary

The randomized control trial study aimed to evaluate effectiveness and safety of amphotericin B in 30% DMSO solution comparing with 30% DMSO solution in NDMs onychomycosis treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Treatments: Amphotericin B; Dimethyl Sulfoxide; Liposomal amphotericin B

Criteria

Inclusion Criteria:

1. Patients with non-dermatophyte onychomycosis.

2. Patients aged more than 18 years.

3. Patients has not been treated with any oral/ IV/ topical antifungal therapy within 36 weeks before enrolled.

Exclusion Criteria:

1. Patients had concomitant nail diseases.

2. Immunocompromised host.

3. Patients with dermatophyte onychomycosis.